Drug Abuse News and Research

RSS

Veterans Affairs partners with NIH to grant award for substance abuse research in military personnel

The Department of Veterans Affairs is partnering with the National Institutes of Health (NIH) to award $6 million in grants for research examining the link between substance abuse and military deployments and combat-related trauma.

26 Aug 2010

Prescription drug abuse soars despite state monitoring programs

Stateline: Over the past 10 years, "prescription drug abuse has soared to new levels. A recent White House study found a 400 percent increase in abuse from 1998 to 2008.

26 Aug 2010

Pharmacies in Massachusetts to make available lock boxes for sale

On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.

18 Aug 2010

Ill effects of methamphetamine

On the street it's known as meth, speed, ice, chalk, crank, fire, glass or crystal. Methamphetamine is a highly addictive drug that wreaks havoc on the entire body, including the user's oral health. Approximately 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.

17 Aug 2010

Titan Pharmaceuticals second-quarter net loss increases to $1.84 million

Titan Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2010.

16 Aug 2010

NIDA grants Selecta Biosciences $3M to develop nicotine vaccine for smoking cessation and relapse prevention

Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.

16 Aug 2010

MeCP2 protein regulates properties of psychostimulant drugs: Research

When a certain protein is mutated or missing, symptoms of the neurodevelopmental disorder Rett syndrome arise, causing a gradual loss of brain function during early development.This fact led Duke University Medical Center researchers to test a theory that the protein might also contribute to nerve-cell connection (synapse) changes in a fully formed adult mouse brain when exposed to psychostimulant use.

16 Aug 2010

MeCP2 regulatory protein determines vulnerability to cocaine addiction: Research

A regulatory protein best known for its role in a rare genetic brain disorder also may play a critical role in cocaine addiction, according to a recent study in rats, funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the journal Nature Neuroscience.

16 Aug 2010

Catalyst second-quarter net loss decreases to $1,328,541

Catalyst Pharmaceutical Partners, Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

13 Aug 2010

First Edition: August 12, 2010

Some of today's headlines highlight how the new health reform law is playing beyond Washington, D.C.'s beltway.

12 Aug 2010

‘Decriminalize’ but not ‘Legalize’ drug abuse says Australian Sex party

Professor Paul Wilson, an Australian criminologist revealed that illegal drug use in Australia costs the nation $3.8 billion every year. Australian Sex Party however claims personal drug use should be decriminalized and drug abusers sent for rehabilitation instead of imprisonment.

10 Aug 2010

SAMHSA survey highlights extent of underage alcohol consumption

A new report released by the Substance Abuse and Mental Health Services Administration (SAMHSA) highlights the extent of the underage drinking problem in the nation through the lens of alcohol-related emergency department visits involving adolescents and young adults aged 12 to 20.

10 Aug 2010

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study

A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana, but that is produced by the body's own nerve cells.

7 Aug 2010

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studies in patients with chronic hepatitis C virus (HCV) genotype 1 infection, the addition of boceprevir to treatment with PEGINTRON® and REBETOL® significantly increased the number of patients who achieved sustained virologic response, compared to control groups that received Peg/riba plus placebo.

5 Aug 2010

USN-DAAT to collect unused, expired prescription and OTC drugs from public

Following the overwhelming success of Southern Nevada's first Operation Medicine Cabinet event in February, University of Southern Nevada's Drug Abuse Awareness team and a coalition of local organizations have come together for a second event to collect unused and expired prescription and over-the-counter drugs from the public.

4 Aug 2010

Opinions: AIDS 2010; Clean water, sanitation; Russia's HIV/AIDS epidemic; Financial tax; Medical abortion in developing countries

A VOA News editorial by the U.S. government reflects on last month's International AIDS Conference-AIDS 2010, including key advancements such as the vaginal microbicide gel found to offer women some protection against HIV infection as well discussions about funding for the fight against HIV/AIDS and how the "criminalization of drug abuse and persecution of homosexuals" in the world is compromising efforts to prevent the spread of the disease.

4 Aug 2010

Titan completes 60% enrollment in confirmatory Phase 3 clinical study of Probuphine for opioid addiction

Titan Pharmaceuticals, Inc. today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule.

3 Aug 2010

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck announced a non-exclusive license agreement with Laboratory Corporation of America Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.

28 Jul 2010

Millennium Laboratories urges for increase in physician reimbursement for POC urine drug screening

Millennium Laboratories, Inc., a national, research-based medication monitoring company specifically focused on clinicians who treat chronic pain, strongly advocated for an increase in physician reimbursement for point-of-care urine drug screening at the Annual Clinical Laboratory Public Meeting of the Centers for Medicare and Medicaid Services on July 22, 2010.

27 Jul 2010

Global Fund director calls on emerging countries to invest more in programs to reduce HIV/AIDS, TB and malaria at AIDS 2010

On the final day of the International AIDS Conference-AIDS 2010 Friday, Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria called upon "China, India and other fast-growing economies" to chip in to help close the funding gap in efforts to battle HIV/AIDS, Agence France-Presse reports. "Until now, these countries have been recipients of AIDS funds, not donors," the news service writes.

27 Jul 2010

Drug Abuse News and Research

Veterans Affairs partners with NIH to grant award for substance abuse research in military personnel

Prescription drug abuse soars despite state monitoring programs

Pharmacies in Massachusetts to make available lock boxes for sale

Ill effects of methamphetamine

Titan Pharmaceuticals second-quarter net loss increases to $1.84 million

NIDA grants Selecta Biosciences $3M to develop nicotine vaccine for smoking cessation and relapse prevention

MeCP2 protein regulates properties of psychostimulant drugs: Research

MeCP2 regulatory protein determines vulnerability to cocaine addiction: Research

Catalyst second-quarter net loss decreases to $1,328,541

First Edition: August 12, 2010

‘Decriminalize’ but not ‘Legalize’ drug abuse says Australian Sex party

SAMHSA survey highlights extent of underage alcohol consumption

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

USN-DAAT to collect unused, expired prescription and OTC drugs from public

Opinions: AIDS 2010; Clean water, sanitation; Russia's HIV/AIDS epidemic; Financial tax; Medical abortion in developing countries

Titan completes 60% enrollment in confirmatory Phase 3 clinical study of Probuphine for opioid addiction

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Millennium Laboratories urges for increase in physician reimbursement for POC urine drug screening

Global Fund director calls on emerging countries to invest more in programs to reduce HIV/AIDS, TB and malaria at AIDS 2010

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News